Showing results (531-540 of 1,087) with videos related to
Sort By:
Pageof 109
Journal of the American College of Cardiology|February 6, 2007
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trialsAlban Dibra, Adnan Kastrati, Fernando Alfonso, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 27, 2023
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysisAndrea Raffaele Munafò, Claudio Montalto, Marco Franzino, et al.European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.International Journal of Cardiology|May 17, 2021
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous interventionDeepak L Bhatt, Juan Carlos Kaski, Sean Delaney, et al.American Heart Journal|October 8, 2020
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stentMarco Valgimigli, Davide Cao, Rajendra R Makkar, et al.Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.Journal of Cardiovascular Development and Disease|June 25, 2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI TrialLuis Ortega-Paz, Claudio Laudani, Alessandro Sionis, et al.Journal of Clinical Medicine|June 12, 2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized TrialLuis Ortega-Paz, Claudio Laudani, Carlos Igor Morr, et al.Pageof 109